default author photo

Hongjie Yu

Fudan University - Key Laboratory of Public Health Safety

China

Fudan University - Shanghai Institute of Infectious Disease and Biosecurity

Shanghai, 200032

China

Government of the People's Republic of China - Ministry of Education

37# Damucang Hutong

Xicheng District

Beijing

China

Fudan University - Department of Infectious Diseases

Shanghai

China

SCHOLARLY PAPERS

5

DOWNLOADS

607

TOTAL CITATIONS

9

Scholarly Papers (5)

1.

Neutralizing Antibodies Against SARS-CoV-2 Variants Induced by Natural Infection or Vaccination: A Systematic Review and Individual Data Meta-Analysis

Number of pages: 104 Posted: 02 Jun 2021
Fudan University - Key Laboratory of Public Health Safety (Ministry of Education), Fudan University, Johns Hopkins University - Department of Epidemiology, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University - Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University - Key Laboratory of Public Health Safety, Ministry of Education, University of Utah - School of Medicine and Fudan University - Key Laboratory of Public Health SafetyFudan University - Shanghai Institute of Infectious Disease and Biosecurity
Downloads 183 (415,884)
Citation 8

Abstract:

Loading...

SARS-CoV-2 variants; neutralizing antibodies; natural infection; vaccination

2.

Surveillance for Adverse Events Following Immunization With COVID-19 Vaccines in Dalian, China

Number of pages: 25 Posted: 24 Jul 2021
Fudan University - Key Laboratory of Public Health Safety, Ministry of Education, Dalian Center for Disease Control and Prevention - Department of Immune Planning, Fudan University - Key Laboratory of Public Health Safety, Ministry of Education, Dalian Center for Disease Control and Prevention - Department of Immune Planning, Fudan University - Key Laboratory of Public Health Safety, Ministry of Education, Dalian Center for Disease Control and Prevention - Department of Immune Planning, Fudan University - Key Laboratory of Public Health Safety, Ministry of Education, Dalian Center for Disease Control and Prevention - Department of Immune Planning, Dalian Center for Disease Control and Prevention - Department of Immune Planning, Dalian Center for Disease Control and Prevention - Department of Immune Planning, Dalian Center for Disease Control and Prevention - Department of Immune Planning, Dalian Center for Disease Control and Prevention - Department of Immune Planning, Dalian Center for Disease Control and Prevention - Department of Immune Planning, Dalian Center for Disease Control and Prevention - Department of Immune Planning and Fudan University - Key Laboratory of Public Health SafetyFudan University - Shanghai Institute of Infectious Disease and Biosecurity
Downloads 181 (418,025)

Abstract:

Loading...

COVID-19 vaccine, safety profile, surveillance, CNAEFIS

3.

Six-Month Follow-Up of a Booster Dose of CoronaVac: Two Single-Centre, Double-Blind, Randomised, Placebo-Controlled Phase 2 Clinical Trials

Number of pages: 26 Posted: 22 Dec 2021
Sinovac Life Sciences Co., Ltd., Fudan University, Fudan University - Key Laboratory of Public Health Safety, Hebei Provincial Center for Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC) - Jiangsu Provincial Center for Disease Control and Prevention, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Fudan University, affiliation not provided to SSRN, Hebei Provincial Center for Disease Control and Prevention, Hebei Provincial Center for Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC) - Jiangsu Provincial Center for Disease Control and Prevention, Fudan University - Key Laboratory of Public Health SafetyFudan University - Shanghai Institute of Infectious Disease and Biosecurity and Sinovac Life Sciences Co., Ltd.
Downloads 132 (551,165)
Citation 1

Abstract:

Loading...

4.

Projecting the Potential Impact of an Omicron XBB Wave in Shanghai, China

Number of pages: 18 Posted: 23 Jun 2023
Fudan University - Key Laboratory of Public Health Safety, Fudan University - Key Laboratory of Public Health Safety, Fudan University - Key Laboratory of Public Health Safety, Fudan University - Key Laboratory of Public Health Safety, Fudan University - Key Laboratory of Public Health Safety, Fudan University - Key Laboratory of Public Health Safety, Fudan University - Key Laboratory of Public Health Safety, Fudan University - Key Laboratory of Public Health Safety, Fudan University - Key Laboratory of Public Health Safety, Fudan University - Key Laboratory of Public Health Safety, Fudan University - Key Laboratory of Public Health Safety, Fudan University - Key Laboratory of Public Health Safety, Indiana University - Laboratory for Computational Epidemiology and Public Health and Fudan University - Key Laboratory of Public Health SafetyFudan University - Shanghai Institute of Infectious Disease and Biosecurity
Downloads 64 (924,743)

Abstract:

Loading...

COVID-19, XBB, disease burden, medical resources, pharmaceutical intervention, non pharmaceutical intervention, modelling

5.

Projecting the Transition of COVID-19 Burden Towards the Young Population While Vaccines are Rolled Out: A Modelling Study

Number of pages: 29 Posted: 01 Oct 2021
Fudan University, Fudan University, Fudan University, Fudan University, Fudan University - Key Laboratory of Public Health Safety (Ministry of Education), Fudan University - Key Laboratory of Public Health Safety, Ministry of Education, Fudan University - Key Laboratory of Public Health Safety, Fudan University, Fudan University, Fudan University - Key Laboratory of Public Health Safety, Fudan University, Indiana University Bloomington and Fudan University - Key Laboratory of Public Health SafetyFudan University - Shanghai Institute of Infectious Disease and Biosecurity
Downloads 47 (1,097,529)

Abstract:

Loading...

novel coronavirus disease 2019, severe acute respiratory syndrome coronavirus 2, Delta variant, vaccination, transition of disease burden, children and adolescents, China